Korea University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Seongbuk-gu Seoul Korea, Republic of (1905)

Organization Overview

First Clinical Trial
1998
NCT03073863
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Anam Hospital, Korea Univeristy College of Medicine | Anesthesia and pain medicine department, Korea University Anam Hospital | Anesthesia and Pain medicine department, Korea University Anam Hospital | Arrhythmia center, Anam hospital, Korea university | Cardiovascular center, Korea University Anam Hospital | Cardiovascular Center, Korea University Guro Hospital, 80, Guro-dong, Guro-gu, Seoul, 152-703, Korea | Department of Anaesthesiology and Pain Medicine Department, Korea University Anam Hospital | Department of Anesthesiology and Pain medicine. Korea universicy medical center. | Department of Cardiology, Korea University Anam Hospital | Department of Cardiovascular, Korea University Guro Hospital | Department of Clinical Pharmacology & Toxicology, Anam Hospital, Korea University College of Medicine | Department of Orthopaedic Surgery at Korea University Guro Hospital | Department of Psychiatry, Korea University Anam Hospital, Korea University College of Medicine | Department of Psychiatry, Korea University Ansan Hospital, Korea University College of Medicine | Department of Psychiatry, Korea University Guro Hospital, Korea University College of Medicine | Department of surgery, Korea university Anam hospital | Department of Surgery, Korea University Guro Hospital, South Korea | Department of Urology, Korea University Anam Hospital | Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Gastrointestinal Medical Instrument Research, Korea University College of Medicine | Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea | Go Eun Bae | Jeong Gu Lee | Korae University Guro Hospital | Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences | Korea Cancer Center Hospital , Seoul, Korea | Korea Univ Ansan Hospital | Korea University | Korea University Anam Hospital | Korea University Anam Hospital' in Seoul, Korea | Korea University Anam Hospital, Seoul, Inchon-ro 8-gil 73, Seoul, Republic of Korea | Korea University Anam Hospital / Seoul, Seongbuk-Gu, South Korea | Korea University Anam Hospitial | Korea University Ansan Hospital | Korea University College of Medicine & Korea University Ansan Hospital | Korea University Guro Hospital | Korea University Hospital | Korea University Hospital, Anam | Korea University Medical Center, Ansan, Kyunggi-do, Korea, Republic of | Korea University Medical Center-Guro | Korea University Medical Center, Seoul, Korea, Republic of | Korea University Medical Centre | Korea Univ. Guro Hospital | Korea Univ. MC | Korea Unversity Ansan Hospital | The Korea University Anam Hospital

Active Ingredients

Drugs in Phase 4 Trials (101)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

5,7-dihydroxy-3',4',6-trimethoxyflavone (1 trial)

acetylsalicylic acid (aspirin) (3 trials)

adefovir dipivoxil (hepsera) (3 trials)

aminosyn ii (1 trial)

amlodipine (norvasc) (9 trials)

atorvastatin (lipitor) (7 trials)

bevacizumab (avastin) (1 trial)

bromocriptine (parlodel) (1 trial)

budesonide (rhinocort) (1 trial)

cefotaxime (claforan) (1 trial)

ceftriaxone (rocephin) (1 trial)

celecoxib (celebrex) (5 trials)

cilostazol (pletal) (4 trials)

ciprofloxacin (cipro) (2 trials)

clopidogrel (plavix) (5 trials)

cyproviron (1 trial)

daclatasvir (daklinza) (2 trials)

dexamethasone (1 trial)

dexmedetomidine (precedex) (3 trials)

diacerein (1 trial)

diltiazem (cardizem) (1 trial)

diphtheria toxoid (1 trial)

entecavir (baraclude) (8 trials)

epinephrine (levophed) (1 trial)

escitalopram (lexapro) (1 trial)

everolimus (zortress) (1 trial)

evolocumab (repatha) (1 trial)

ezetimibe (zetia) (4 trials)

fentanyl (Innovar) (3 trials)

fimasartan (kanarb) (7 trials)

glimepiride (amaryl) (3 trials)

hifenac (1 trial)

idflu (1 trial)

imatinib (gleevec) (1 trial)

inactivated influenza vaccine (18 trials)

ingenol mebutate (picato) (1 trial)

insulin human (humulin) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

lacidipine (motens) (1 trial)

lamivudine (epivir) (4 trials)

levocarnitine (carnitor) (1 trial)

lobeglitazone (5 trials)

manidipine hydrochloride (1 trial)

methylprednisolone (medrol) (1 trial)

misoprostol (cytotec) (1 trial)

montelukast (singulair) (2 trials)

motilitone (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

naftopil (1 trial)

nateglinide (starlix) (1 trial)

nebivolol (bystolic) (2 trials)

neostigmine (bloxiverz) (1 trial)

norfloxacin (noroxin) (1 trial)

octreotide (sandostatin) (1 trial)

pioglitazone (actos) (4 trials)

pitavastatin (livalo) (2 trials)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (4 trials)

ppv-23 (2 trials)

pramipexole (mirapex) (1 trial)

prasugrel (effient) (1 trial)

progesterone (progestasert) (1 trial)

propofol (diprivan) (7 trials)

propranolol (inderal) (2 trials)

ranibizumab (lucentis) (1 trial)

remifentanil (ultiva) (1 trial)

remimazolam (2 trials)

ribavirin (virazole) (1 trial)

rocuronium (zemuron) (7 trials)

ropivacaine (naropin) (1 trial)

rosuvastatin (crestor) (8 trials)

rubus occidentalis extract (1 trial)

salsalate (salflex) (1 trial)

sarpogrelate (1 trial)

sevoflurane (ultane) (2 trials)

silodosin (rapaflo) (1 trial)

sirolimus (rapamune) (2 trials)

sitagliptin (januvia) (8 trials)

solifenacin (vesicare) (2 trials)

somatostatin (2 trials)

sorafenib (nexavar) (2 trials)

spasmopriv (1 trial)

sugammadex (bridion) (3 trials)

sunvepra (2 trials)

taltirelin tetrahydrate (1 trial)

telbivudine (tyzeka) (1 trial)

telmisartan (micardis) (2 trials)

teneligliptin hydrobromide hydrate (1 trial)

tenofovir (viread) (6 trials)

tenofovir alafenamide (genvoya) (1 trial)

terlipressin (1 trial)

tetanus toxoid (1 trial)

ticagrelor (brilinta) (1 trial)

tolvaptan (samsca) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

trimebutine (1 trial)

urea (2 trials)

valsartan (diovan) (5 trials)

vasopressin (vasostrict) (1 trial)

vildagliptin (2 trials)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 3 Trials (71)

agsct101 (1 trial)

agspt201 (1 trial)

allo-asc-dfu (1 trial)

allogeneic adipose derived mesenchymal stem cell (5 trials)

aso3 (1 trial)

autologous culture chondrocytes (Carticel) (1 trial)

avanafil (stendra) (1 trial)

azd1222 (1 trial)

besifovir (1 trial)

bisacodyl (Halflytely) (1 trial)

bremelanotide (Vyleesi) (1 trial)

candesartan (atacand) (1 trial)

capecitabine (xeloda) (4 trials)

carvedilol (coreg) (1 trial)

ckd-330 (1 trial)

cyclosporine (sandimmune) (2 trials)

da-2802 (1 trial)

da-3002 (3 trials)

dabigatran (pradaxa) (2 trials)

dapagliflozin (farxiga) (3 trials)

dp-r208 (1 trial)

famotidine (pepcid) (1 trial)

filgrastim (neupogen) (2 trials)

fluarix (1 trial)

furestem (1 trial)

gbp510 (3 trials)

gemcitabine (gemzar) (4 trials)

gimeracil (1 trial)

gv 1001 (1 trial)

hantavax (1 trial)

hl-040xc (1 trial)

hyaluronic acid (1 trial)

hydrochlorothiazide (esidrix) (2 trials)

icosapent ethyl (vascepa) (1 trial)

immune globulin (human) (1 trial)

irinotecan (Camptosar) (1 trial)

levamlodipine (Conjupri) (1 trial)

linagliptin (tradjenta) (2 trials)

lipiodol (1 trial)

live attenuated varicella vaccine (4 trials)

losartan (cozaar) (4 trials)

mg1109 (2 trials)

mitiglinide (1 trial)

moxifloxacin (avelox) (1 trial)

nafamostat (ronastat) (1 trial)

nbp607 (5 trials)

olmesartan (benicar) (1 trial)

omeprazole (prilosec) (1 trial)

ondansetron (zofran) (2 trials)

oteracil (1 trial)

oxaliplatin (eloxatin) (3 trials)

picolight (1 trial)

polyethylene glycol (4 trials)

protecadin (1 trial)

ramosetron (1 trial)

rebamipide (3 trials)

recoflavone (1 trial)

s-1 (1 trial)

sargramostim (leukine) (2 trials)

saxagliptin (onglyza) (1 trial)

simethicone (1 trial)

sodium picosulfate (1 trial)

somatropin (protropin) (2 trials)

tegafur (1 trial)

tjo-087 (1 trial)

trimagnesium dicitrate (1 trial)

udenafil (2 trials)

vitamin c (2 trials)

xenobella (1 trial)

zabofloxacin (1 trial)

zemiglo (2 trials)

Drugs in Phase 2 Trials (48)

131i-rituximab (2 trials)

ad209 (2 trials)

ad-209 (1 trial)

allogeneic plx-pad cells (1 trial)

aluminum hydroxide (Gaviscon) (1 trial)

anastrozole (arimidex) (2 trials)

apixaban (eliquis) (1 trial)

as03 (1 trial)

bls_ilb_710c (1 trial)

bls-ilb-e710c (1 trial)

bls_ils_e710c (1 trial)

caffeine (1 trial)

carboplatin (paraplatin) (1 trial)

ciclesonide (alvesco) (1 trial)

cisplatin (platinol) (2 trials)

clevudine (1 trial)

da-8031 (1 trial)

dienogest (natazia) (1 trial)

docetaxel (taxotere) (1 trial)

dovitinib (1 trial)

erlotinib (tarceva) (1 trial)

etoposide (vepesid) (1 trial)

ferrous sulfate (1 trial)

fulvestrant (faslodex) (1 trial)

gefitinib (iressa) (1 trial)

goserelin (zoladex) (1 trial)

gx-188e (2 trials)

hydroxychloroquine (plaquenil) (2 trials)

ifosfamide (ifex) (1 trial)

immuncell-lc (1 trial)

iron isomaltoside (1 trial)

lapatinib (tykerb) (1 trial)

lazertinib (2 trials)

l-glutamic acid (1 trial)

mg1111 (1 trial)

pemetrexed (alimta) (2 trials)

polmacoxib (1 trial)

prednisone (meticorten) (1 trial)

rivaroxaban (xarelto) (1 trial)

sodium chloride (2 trials)

sp-8203 (1 trial)

suduvax (1 trial)

tacrolimus (prograf) (1 trial)

titanium silicide (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

vinorelbine (navelbine) (1 trial)

warfarin (coumadin) (2 trials)

yh14617 (1 trial)

Drugs in Phase 1 Trials (29)

99mtc-msa-icg (1 trial)

amitriptyline (elavil) (1 trial)

antithrombin iii (human) (thrombate iii) (1 trial)

ast-021p (1 trial)

bacille calmette-guerin (1 trial)

bepotastine (bepreve) (2 trials)

cj-30060 (1 trial)

ckd-519 (2 trials)

clomidazole (1 trial)

donepezil (aricept) (1 trial)

febuxostat (uloric) (1 trial)

fenofibrate (fenoglide) (2 trials)

finasteride (Proscar) (1 trial)

hcp0912 (1 trial)

hybrid 5 component dtap, vero ipv, hep b and prp-ompc (1 trial)

irbesartan (avapro) (1 trial)

metformin (glucophage) (2 trials)

mg1113 (1 trial)

nilotinib (tasigna) (1 trial)

oseltamivir (tamiflu) (2 trials)

raloxifene (evista) (1 trial)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

simvastatin (zocor) (2 trials)

tamsulosin (flomax) (1 trial)

testosterone (delatestryl) (1 trial)

tocilizumab (actemra) (1 trial)

varenicline (chantix) (1 trial)

vgx-3400 (1 trial)

vitamin d3 (1 trial)

Drugs in Other Trials (20)

alcohol dehydrogenase (1 trial)

aripiprazole (abilify) (1 trial)

curcumin (1 trial)

edoxaban (savaysa) (1 trial)

etomidate (amidate) (1 trial)

flecainide (tambocor) (1 trial)

fludeoxyglucose f-18 (1 trial)

gen-001 (1 trial)

ginseng (1 trial)

hydromorphone (diladid) (1 trial)

ketamine (ketalar) (1 trial)

ketorolac (acuvail) (1 trial)

letrozole (femara) (1 trial)

lidocaine (xylocaine) (1 trial)

midazolam (versed) (1 trial)

nitrous oxide (1 trial)

propafenone (rythmol) (1 trial)

rivastigmine (exelon) (1 trial)

sun 1165 (1 trial)

tamoxifen (nolvadex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Adenocarcinoma (Phase 2)

Adenoma (Phase 3)

Alzheimer Disease (Phase 4)

Angina Pectoris (Phase 4)

Angina, Stable (Phase 4)

Angina, Unstable (Phase 4)

Aortic Valve Stenosis (Phase 4)

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 3)

Arthritis, Psoriatic (Phase 3)

Arthritis, Rheumatoid (Phase 4)

Ascites (Phase 4)

Asthma (Phase 4)

Ataxia (Phase 4)

Atherosclerosis (Phase 4)

Atrial Fibrillation (Phase 3)

Birth Weight (Phase 2)

Breast Neoplasms (Phase 4)

Bronchopulmonary Dysplasia (Phase 2)

Cancer Pain (Phase 2)

Carcinoma (Phase 4)

Carcinoma, Hepatocellular (Phase 4)

Carcinoma in Situ (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Cardiovascular Diseases (Phase 4)

Cerebral Infarction (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 2)

Chickenpox (Phase 1)

Colorectal Neoplasms (Phase 3)

Constriction, Pathologic (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Coronary Stenosis (Phase 4)

Coronary Vasospasm (Phase 4)

Crohn Disease (Phase 4)

Depression (Phase 4)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Foot (Phase 3)

Diabetic Nephropathies (Phase 4)

Diphtheria (Phase 4)

Dry Eye Syndromes (Phase 3)

Dwarfism (Phase 3)

Dyslipidemias (Phase 3)

Dyspepsia (Phase 4)

Eczema (Phase 2)

Edema (Phase 4)

Emergence Delirium (Phase 4)

Endometriosis (Phase 2)

Enuresis (Phase 4)

Erectile Dysfunction (Phase 3)

Esophagitis (Phase 3)

Esophagitis, Peptic (Phase 3)

Essential Hypertension (Phase 3)

Fatty Liver (Phase 4)

Fibrosis (Phase 4)

Foot Ulcer (Phase 3)

Gastritis (Phase 3)

Gastroesophageal Reflux (Phase 3)

Glomerulonephritis (Phase 3)

Glucose Intolerance (Phase 4)

Gonadal Dysgenesis (Phase 3)

Haemophilus Infections (Phase 1)

Heart Arrest (Phase 4)

Heart Diseases (Phase 4)

Hemarthrosis (Phase 4)

Hemophilia A (Phase 1)

Hemorrhage (Phase 4)

Hepatic Insufficiency (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Herpes Zoster (Phase 3)

Hyperlipidemia, Familial Combined (Phase 3)

Hyperlipidemias (Phase 4)

Hyperlipoproteinemias (Phase 4)

Hyperplasia (Phase 4)

Hypertension (Phase 4)

Hypogonadism (Phase 1)

Hyponatremia (Phase 4)

Hypothyroidism (Phase 4)

Infarction (Phase 4)

Infertility (Phase 1)

Influenza, Human (Phase 4)

Intermittent Claudication (Phase 2)

Irritable Bowel Syndrome (Phase 4)

Ischemia (Phase 4)

Ischemic Attack, Transient (Phase 2)

Keratoconjunctivitis Sicca (Phase 3)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Leukemia (Phase 4)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 4)

Leukemia, Myeloid (Phase 4)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Liver Cirrhosis (Phase 4)

Liver Diseases (Phase 4)

Liver Failure (Phase 3)

Lower Urinary Tract Symptoms (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, T-Cell (Phase 2)

Macular Edema (Phase 4)

Metabolic Syndrome (Phase 4)

Muscle Hypotonia (Phase 4)

Myelodysplastic Syndromes (Phase 2)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Neointima (Phase 4)

Neoplasm Metastasis (Phase 4)

Neoplasms (Phase 3)

Neuralgia (Phase 4)

Neuralgia, Postherpetic (Phase 4)

Neutropenia (Phase 3)

Non-alcoholic Fatty Liver Disease (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Osteoporosis (Phase 1)

Out-of-Hospital Cardiac Arrest (Phase 4)

Pain, Postoperative (Phase 4)

Pancreatic Neoplasms (Phase 3)

Parkinson Disease (Phase 4)

Peripheral Arterial Disease (Phase 2)

Peritonitis (Phase 4)

Pneumococcal Infections (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Pneumococcal (Phase 4)

Poliomyelitis (Phase 1)

Prediabetic State (Phase 4)

Premature Birth (Phase 2)

Premature Ejaculation (Phase 2)

Prostatic Hyperplasia (Phase 4)

Prostatic Neoplasms (Phase 2)

Pruritus (Phase 1)

Psychomotor Agitation (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Recurrence (Phase 2)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Rhinitis (Phase 1)

Rhinitis, Allergic (Phase 1)

Rhinitis, Allergic, Perennial (Phase 1)

Rupture (Phase 4)

Sarcoma (Phase 2)

Sepsis (Phase 3)

Shock (Phase 3)

Shock, Septic (Phase 3)

Spinal Cord Injuries (Phase 1)

Spinal Diseases (Phase 4)

Spinocerebellar Ataxias (Phase 4)

Spinocerebellar Degenerations (Phase 4)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Stroke (Phase 4)

Syndrome (Phase 4)

Tetanus (Phase 4)

Tetany (Phase 4)

Thromboembolism (Phase 3)

Toxemia (Phase 3)

Tuberculosis (Phase 1)

Turner Syndrome (Phase 3)

Ulcer (Phase 3)

Urinary Bladder, Overactive (Phase 3)

Urinary Incontinence (Phase 4)

Urinary Incontinence, Stress (Phase 4)

Urticaria (Phase 1)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 283
  • # of Trial APIs: 269